公司概覽
業務類別 Medical Devices
業務概覽 Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
公司地址 One Edwards Way, Irvine, CA, USA, 92614
電話號碼 +1 949 250-2500
傳真號碼 +1 949 250-2525
公司網頁 https://www.edwards.com
員工數量 16000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Daniel J. Lippis Corporate Vice President, Transcatheter Aortic Valve Replacemen -- 25/07/2025
Mr. Wayne Markowitz General Manager and Senior Vice President, Surgical Structural Heart -- 26/03/2025
Ms. Annette Bruls Corporate Vice President, EMEACLA -- 26/03/2025
Mr. Daveen Chopra Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies 美元 627.35K 26/03/2025
Mr. Bernard J. Zovighian Director and Chief Executive Officer 美元 1.13M 25/02/2026
Mr. Andrew M. Dahl Principal Accounting Officer, Senior Vice President and Corporate Controller -- 25/02/2026
Mr. Donald E. Bobo,Jr Corporate Vice President 美元 737.05K 26/03/2025
Mr. Scott B. Ullem Corporate Vice President and Chief Financial Officer 美元 774.33K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Paul A. Laviolette Independent Director 25/02/2026
Mr. Nicholas J. Valeriani Chairman of the Board 25/02/2026
Ms. Ramona A. Sequeira Independent Director 25/02/2026
Mr. Bernard J. Zovighian Director and Chief Executive Officer 25/02/2026
Mr. Steven R. Loranger Independent Director 25/02/2026
Mr. Kieran T. Gallahue Independent Director 25/02/2026
Ms. Leslie C. Davis Independent Director 25/02/2026
Dr. David T. Feinberg, M.D.,PhD Director 25/02/2026
Ms. Leslie Stone Heisz Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:14)
代號 名稱 佔比% 持有日期
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.0001%26/02/2026
TPLETimothy Plan US Large/Mid Cp Cr Enh ETF0.0001%02/10/2025
TECHarbor Transformative Technologies ETF0.0001%28/02/2026
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%27/02/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%27/02/2026
AVTMAvantis Total Equity Markets ETF0.0001%28/02/2026
HQGOHartford US Quality Growth ETF0.0001%28/02/2026
XVOLAcruence Active Hedge US Equity ETF0.00005%27/02/2026
AVLVAvantis US Large Cap Value ETF0.00004%28/02/2026
GOFGuggenheim Strategic Opp Fund0.00004%30/11/2025
QFRDPacer S&P 500 Quality FCF R&D LeadersETF0.00004%27/02/2026
QQHGInvesco QQQ Hedged Advantage ETF0.00003%27/02/2026
INROiShares U.S. Industry Rotation Act ETF0.00003%28/02/2026
AVUQAvantis U.S. Quality ETF0.00002%28/02/2026
ESLVEventide Large Cap Value ETF0.00001%27/02/2026
CHRIGlobal X S&P 500 Christian Values ETF0.00001%27/02/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00001%23/02/2026
RVRBReverb ETF0.00001%27/02/2026
BDVLiShares Disciplined Vol Eq Act ETF0.00001%13/02/2026
GXLCGlobal X U.S. 500 ETF0.00001%27/02/2026
  1    2    3    4    5    6    7    8    9    10    11   12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.